Keyword Connections

alzheimer's disease

Journals

44

1 European journal of medicinal chemistry

2 Bioorganic chemistry

3 Scientific reports

4 Heliyon

5 Journal of food biochemistry

6 Neuropharmacology

7 International journal of biological macromolecules

8 Behavioural brain research

9 Medicine

10 Theranostics

11 contemporary clinical trials communications

12 medicinal research reviews

13 Environmental research

14 Frontiers in bioengineering and biotechnology

15 computational and structural biotechnology journal

16 alzheimer's & dementia (new york, n y)

17 neurobiology of aging

18 IEEE Transactions on Neural Networks and Learning Systems

19 alzheimer's & dementia (amsterdam, netherlands)

20 international journal of nursing studies

21 NeuroImage

22 The Journal of neuroscience : the official journal of the Society for Neuroscience

23 the journal of pediatrics

24 Frontiers in neuroscience

25 Journal of the American Geriatrics Society

26 mayo clinic proceedings

27 Clinical radiology

28 urologic oncology

29 geriatrie et psychologie neuropsychiatrie du vieillissement

30 frontiers in neurology

31 pharmacology research & perspectives

32 international journal of radiation oncology, biology, physics

33 Journal of the neurological sciences

34 Medical image analysis

35 international journal of language & communication disorders

36 the annals of thoracic surgery

37 drug development research

38 current alzheimer research

39 journal of the american medical directors association

40 European journal of neurology

41 Alzheimer's & dementia : the journal of the Alzheimer's Association

42 child development

43 soins gerontologie

44 journal of thyroid research

Research Groups

0

No Research Group Connected

Bibliographies

314

1 Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adults.

2 [Understanding the suffering of the elderly].

3 Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent.

4 Nutrition, Growth, Brain Volume, and Neurodevelopment in Very Preterm Children.

5 Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume.

6 Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.

7 The case-finding study: A novel community-based research recruitment approach for engaging participants with early cognitive decline.

8 Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease.

9 Energy Disaggregation via Deep Temporal Dictionary Learning.

10 Passive Digital Signature for Early Identification of Alzheimer's Disease and Related Dementia.

11 Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy.

12 Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain Atrophy.

13 TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): Protocol for a systematic review and network meta-analysis.

14 Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease.

15 Biomaterials and Advanced Biofabrication Techniques in hiPSCs Based Neuromyopathic Disease Modeling.

16 Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening.

17 A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy.

18 Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.

19 Study of Vitamin D Level and Vitamin D Receptor Polymorphism in Hypothyroid Egyptian Patients.

20 Replay by authors: Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer.

21 Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration.

22 Quercetin reduces eIF2α phosphorylation by GADD34 induction.

23 Probing the interaction of Rivastigmine Tartrate, an important Alzheimer's drug, with serum albumin: Attempting treatment of Alzheimer's disease.

24 Cardiopulmonary Bypass: How I Teach It.

25 Rho-kinase ROCK inhibitors reduce oligomeric tau protein.

26 Endothelial Vascular Function as a Surrogate of Vascular Risk and Aging in Women.

27 Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388.

28 Discourse macrolinguistic impairment as a marker of linguistic and extralinguistic functions decline in early Alzheimer's disease.

29 Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer's Disease.

30 Aligning Requirements of Training and Assessment in Radiation Treatment Planning in the Era of Competency-Based Medical Education.

31 Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.

32 Young Children's Mathematical Learning From Intelligent Characters.

33 Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution.

34 Oral treatment with royal jelly improves memory and presents neuroprotective effects on icv-STZ rat model of sporadic Alzheimer's disease.

35 Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses.

36 A training program for primary health care nurses on timely diagnosis and management of dementia in general practice: An evaluation study.

37 Evaluating the Efficacy of a Web-Based Program (Diapason) for Informal Caregivers of Patients With Alzheimer’s Disease: Protocol for a Randomized Clinical Trial

38 A Web-Based Program for Informal Caregivers of Persons With Alzheimer’s Disease: An Iterative User-Centered Design

39 Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.

40 Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.

41 scorpion venom heat-resistant peptide protects transgenic caenorhabditis elegans from β- amyloid toxicity

42 associative agreement as a predictor of naming ability in alzheimer's disease: a case for the semantic nature of associative links

43 modulation of brain activity with noninvasive transcranial direct current stimulation (tdcs): clinical applications and safety concerns

44 crispr/cas9 mediated disruption of the swedish app allele as a therapeutic approach for early-onset alzheimer’s disease

45 mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic alzheimer's disease

46 adnp: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration

47 dna demethylation upregulated nrf2 expression in alzheimer's disease cellular model

48 novel therapies for treatment of alzheimers disease

49 deep brain stimulation as a tool for improving cognitive functioning in alzheimer’s dementia: a systematic review

50 fast parallel image registration on cpu and gpu for diagnostic classification of alzheimer's disease

51 the potential of epigenetic therapies in neurodegenerative diseases

52 mitochondrial protection by the mixed muscarinic/σ1 ligand anavex2-73, a tetrahydrofuran derivative, in aβ25-35 peptide-injected mice, a nontransgenic alzheimer's disease model

53 differential contributions of apoe4 and female sex to bace1 activity and expression mediate aβ deposition and learning and memory in mouse models of alzheimer’s disease

54 alzheimer’s disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: an exploratory study

55 a systems view of the differences between apoe ε4 carriers and non-carriers in alzheimer’s disease

56 dysregulation of the hpa axis as a core pathophysiology mediating co-morbid depression in neurodegenerative diseases

57 a lentiviral sponge for mir-101 regulates ranbp9 expression and amyloid precursor protein metabolism in hippocampal neurons

58 trabalho de consenso de força-tarefa da wfsbp sobre marcadores biológicos das demências: contribuição da análise do lcr e do sangue para o diagnóstico precoce e diferencial das demências consensus paper of the wfsbp task force on biological markers of dementia: the role of csf and blood analysis in the early and differential diagnosis of dementia (world j biol psychiatry. 2005;6(2):69-84. review)

59 embodied cognition of aging

60 unique pharmacological property of isrib in inhibition of aβ-induced neuronal cell death

61 editorial: the metabolic-inflammatory axis in brain aging and neurodegeneration

62 jagged1 is altered in alzheimer's disease and regulates spatial memory processing

63 rey's auditory verbal learning test scores can be predicted from whole brain mri in alzheimer's disease

64 exosomes as carriers of alzheimer's amyloid-ß

65 graph theoretic analysis of structural connectivity across the spectrum of alzheimer's disease: the importance of graph creation methods

66 tailored lighting intervention improves measures of sleep, depression, and agitation in persons with alzheimer’s disease and related dementia living in long-term care facilities

67 cerebral microbleeds: a review of clinical, genetic and neuroimaging associations

68 nsaids may protect against age-related brain atrophy

69 the porphyromonas gingivalis/host interactome shows enrichment in gwasdb genes related to alzheimer's disease, diabetes and cardiovascular diseases

70 control of intracellular calcium signaling as a neuroprotective strategy

71 the neural correlates of unsuccessful memory performance in mci

72 polysaccharides from ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of alzheimer's disease

73 global analysis of ginsenoside rg1 protective effects in β-amyloid-treated neuronal cells

74 all in the family: how the apps regulate neurogenesis

75 nutrition, frailty, and alzheimer's disease

76 can insulin signaling pathways be targeted to transport aβ out of the brain?

77 comparison of the effects of transdermal and oral rivastigmine on cognitive function and eeg markers in patients with alzheimer's disease

78 automated spatial brain normalization and hindbrain white matter reference tissue give improved [18f]-florbetaben pet quantitation in alzheimer´s model mice

79 histamine h3 receptor inverse agonists on cognitive and motor processes: relevance to alzheimer’s disease, adhd, schizophrenia and drug abuse

80 regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (trem2)

81 the anti-inflammatory effects of lipoxygenase and cyclo-oxygenase inhibitors in inflammation-induced human fetal glia cells and the aβ degradation capacity of human fetal astrocytes in an ex vivo assay

82 prevalence of dementia subtypes in a developing country: a clinicopathological study

83 hsv-1 and alzheimer’s disease: more than a hypothesis

84 Improving predictive models for Alzheimer’s disease using GWAS data by incorporating misclassified samples modeling

85 Urine dicarboxylic acids change in pre-symptomatic Alzheimer’s disease and reflect loss of energy capacity and hippocampal volume

86 Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia

87 Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

88 Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer’s disease differ according to disease severity and amyloid positivity

89 A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer’s disease

90 Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s disease

91 C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease

92 Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

93 Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons

94 Inhibition of the ubiquitin-proteasome system in Alzheimer's disease

95 Astrocyte senescence promotes glutamate toxicity in cortical neurons

96 The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data

97 Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer’s disease

98 16 Clinical course and the neglected half of Alzheimer's disease (AD)

99 Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients

100 What’s not in the news headlines or titles of Alzheimer disease articles? #InMice

101 Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis